Inhibiting notch activity in breast cancer stem cells by glucose functionalized nanoparticles carrying γ-secretase inhibitors

V. Mamaeva, R. Niemi, M. Beck, E. Özliseli, D. Desai, S. Landor, T. Gronroos, P. Kronqvist, I.K.N. Pettersen, E. McCormack, J.M. Rosenholm, M. Linden, C.M. Sahlgren

Research output: Contribution to journalArticleAcademicpeer-review

52 Citations (Scopus)
102 Downloads (Pure)

Abstract

Cancer stem cells (CSCs) are a challenge in cancer treatment due to their therapy resistance. We demonstrated that enhanced Notch signaling in breast cancer promotes self-renewal of CSCs that display high glycolytic activity and aggressive hormone-independent tumor growth in vivo. We took advantage of the glycolytic phenotype and the dependence on Notch activity of the CSCs and designed nanoparticles to target the CSCs. Mesoporous silica nanoparticles were functionalized with glucose moieties and loaded with a γ-secretase inhibitor, a potent interceptor of Notch signaling. Cancer cells and CSCs in vitro and in vivo efficiently internalized these particles, and particle uptake correlated with the glycolytic profile of the cells. Nanoparticle treatment of breast cancer transplants on chick embryo chorioallantoic membranes efficiently reduced the cancer stem cell population of the tumor. Our data reveal that specific CSC characteristics can be utilized in nanoparticle design to improve CSC-targeted drug delivery and therapy.

Original languageEnglish
Pages (from-to)926-936
Number of pages11
JournalMolecular Therapy
Volume24
Issue number5
DOIs
Publication statusPublished - 1 May 2016

Fingerprint Dive into the research topics of 'Inhibiting notch activity in breast cancer stem cells by glucose functionalized nanoparticles carrying γ-secretase inhibitors'. Together they form a unique fingerprint.

  • Cite this

    Mamaeva, V., Niemi, R., Beck, M., Özliseli, E., Desai, D., Landor, S., Gronroos, T., Kronqvist, P., Pettersen, I. K. N., McCormack, E., Rosenholm, J. M., Linden, M., & Sahlgren, C. M. (2016). Inhibiting notch activity in breast cancer stem cells by glucose functionalized nanoparticles carrying γ-secretase inhibitors. Molecular Therapy, 24(5), 926-936. https://doi.org/10.1038/mt.2016.42